GL1X · GenesisL1 explorer

MolNFT v1 · #71794 · protein

The ternary death domain complex of MYD88, IRAK4, and IRAK2

3MOP · Myeloid differentiation primary response protein MYD88: “The ternary death domain complex of MYD88, IRAK4, and IRAK2”. X-ray diffraction, 20 pockets (best druggability 0.89). MolNFT v1 #71794 on GenesisL1: 3D structure, binding…

PDB
3MOP
Type
protein
Length
1,430 residues
Chains
14
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Myeloid differentiation primary response protein MYD88; Interleukin-1 receptor-associated…
EC
2.7.11.1
UniProt
Q99836, Q9NWZ3, O43187
Pockets
20 · best druggability 0.89

Structure

x-ray diffraction · 3 distinct chains · 54% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, D, E, FMyeloid differentiation primary response protein MYD88protein10555% helix, 0% strandQ99836
G, H, I, JInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein10753% helix, 4% strandQ9NWZ3
K, L, M, NInterleukin-1 receptor-associated kinase-like 2protein9353% helix, 2% strandO43187

Pockets

20 pockets found on a 1 Å grid, 14 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18400.890.92125empty
22110.780.9231empty
31350.750.9329empty
41050.690.9225empty
55260.680.7958empty

Interfaces

40 interfaces between chains.

  • B–E · 656 Ų buried · 13 hydrogen bonds · protein-protein
  • A–D · 651 Ų buried · 12 hydrogen bonds · protein-protein
  • I–M · 647 Ų buried · 6 hydrogen bonds · protein-protein
  • H–L · 641 Ų buried · 10 hydrogen bonds · protein-protein
  • K–N · 629 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 3MOP · The ternary Death Domain complex of MyD88, IRAK4, and IRAK2 · the same entry in another collection · chain N against N, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.